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  1!>'	'"/ 1 s>  13  /
UA=#  
 4 20 ) !7/48  (K
 1!>'	'"/49/3-00/3  B'"12  !  
)26/29  1!>'	'"/ (K99/3-50/3  / '"  
9 ) !9/21 2 1!>'	'"/ (K   
4 .'4 '"  
 K  "! .h# 1 High-flux / 
U@9  1!>'	'"/ 49/3-00/3 '" B  
99/3-50/3  2 / '"4 '"B KT/V    
 D##18/0 ± 46/1B 09/0 ± 56/1 / 12/0 ± 44/1 
/ KT/V  K Low-flux  D## 03/0 ± 44/1B 
16/0 ± 40/1 / 12/0 ± 34/1 ! )090/0  =P 
  .,A229/0  =P bf#  E!#  .(
 K W!  "! .h# 1  !	!
- :Y'M 4 '>  0 1  
) n289/0  =P.(  S/E1  nKT/V  
 10  1!>'	'"/ 1 DA9 .  
 4 '> K W!  !,"I bf#
- :Y'M  10 1  i !   

 K  "  !,"I bf#High-flux  '0
) !001/0 < P.( / UA	
 bf#  E!#   A
 4 '> K W! B  - :Y'M  
 ) n 0 1191/0  =P / 870/0  =P B(
  bf#PTH  :Y'M '> ! K W! 
-  10 i  !    
  K !
High-flux  BPTH ) ! 4 '
008/0  =P.(  
 R*41  n nKT/V   / / 
 -"c C/ / S/ R9   T,# q' .4
' / " .
   /   n0I 
-"c  	9  /B S/E  %*#  2  q' /
 S/E  K W! s>  	
 -@#3  I
.>.  q'   W!@ n b!KKT/V  /
f# n  n0I bHb )Hemoglobin( B
Hct )Hematocrit( BCa )Calcium( BP )Phosphor(B 
Alb )Albumin ( /PTH   	9   / 
 -"c .4  
  	
 !B  B!	! 
  k(0
 ."9  #/# A / UA	
 B.
!#  
High-flux  /Low-flux '4 i  KT/V B
/ !,"I PTH b/#  -  '4 i   
!  
KT/V   '> R9  !,"I /
 KHigh-flux '0 4 B PTH  . 3
 .
W!@ B # !E/ Z R!+ > 
 #[  !#  
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kM4    4 '4 B4  3=  Z#[  .,{
K  High-flux  K  .,A   Low-flux 
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 .4  10 -"cB   !E/ 
  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 1 . KT/V  !	"#$!	"! !% &'( 	) )UF  Ultrafiltration(  
 UF )Liter(  





 4>    P 
High-flux  
 ()*)± )+ ,-   18/0 ± 46/1  99/0 ± 56/1  12/0 ± 44/1  098/0  
Low-flux 
 ()*)± )+ ,-  15/0 ± 44/1 16/0 ± 40/1 12/0 ± 34/1  229/0  
 
 2 ."$  %  -"  .! #(	 	/  0/1.2 3/  
$% 
&	' ()	*  
+  
, & -	 .  , & -	 /0  
High-flux  Low-flux  
 P*  
High-flux  Low-flux  
 P*  234	 ±  54
	-  
234	 ±  54
	-  
234	 ±  54
	-  
234	 ±  54
	-  
KT/V 13/0 ± 46/1 13/0 ± 44/1 716/0 17/0 ± 50/1 16/0 ± 37/1 017/0 
) ()2"3"g/dl(  80/0 ± 80/ -0 00/1 ± 93/0- 642/0 91/0 ± 18/0 93/0 ± 83/0 268/0 
 678"9)( 40/2 ± 02/2- 30/2 ± 12/1- 231/0 83/2 ± 76/0 86/2 ± 56/2 050/0 
:);8 )mg/dl(  47/0 ± 00/0 54/0 ± 02/0 381/0 40/0 - ± 00/0 60/0 ± 31/0 268/0 
 ;<)mg/dl(  11/1 ± 22/0 88/0 ± 22/0 990/0 60/0 - ± 29/0 - 80/0 - ± 11/0 469/0 
) ()"=>?g/dl(  61/0 ± 87/0 42/0 ± 24/0 001/0 <   52/0 ± 71/0 52/0± 10/0 - 001/0 <  
) )@A)9 ""pg/ml(  00/100 ± 95/58 00/144 ± 34/52 866/0 00/166± 30/30 - 00/157 ± 00/83 018/0 











Low- High flux High-Low flux
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 	%&  
 3 ."$  %  0# -" 0$5 6 7 ! 	) 0/1.2 3/  
$%  
&	' ()	*  
+  
6 748  
High-flux  Low-flux  
 P*  
 234	± 	- 54   234	± 	- 54  
KT/V 02/0 ± 48/1 02/0 ± 40/1 013/0 
) ()2"3"g/dl( 15/0 ± 32/0- 20/0 ± 03/0- 289/0 
 678"9)( 46/0 ± 66/0- 49/0 ± 76/0 070/0 
) :);8mg/dl( 07/0 ± 01/0 09/0 ± 17/0 191/0 
) ;<mg/dl( 15/0 ± 29/0 14/0 ± 05/0 870/0 
) ()"=>?g/dl( 09/0 ± 79/0 08/0 ± 07/0 001/0 < 
 "") )@A)9pg/ml( 00/22 ± 40/15 00/23 ± 04/68 008/0 
  
-"c   9j   " .
  / 	
 !
 4  b-"c  .,A K W!  
o!	c ! #.  
 / /   P B  l  " .

 ! o!	c 9  4 &-# '>i   
'  10  
 KT/V    - !  
K  "! High-flux   "!  .,A
 KLow-flux ! '0.  " .
 .!	c
  / /   K o('  4 1!#  
1  D>'B   c> * BUN 
,>h / "!     KT/V    
  .,A 
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"!   <# 
j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K  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  T>!' 
Low-flux ! 4 >B  S!*"! a	
 
T>!' )12Vitamin B / '   ("!!	/* /
	9   	9  .,A C/  3 S/
- ) .4 001/0 < P B030/0 < P/ ( 
 3 K  "!  1!>'	'"/   
Low-flux S!*"!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  .
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 
  3  "B  #Z .4  [
S!*"!  %P!
  )Cr-BUN-P(  .4  
)970/0  =P B240/0 = P / 360/0  =P) (61.( 
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 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 :Y'M  
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High-flux  /  
Low-flux  /PTH  "! .h# 1
!
 
! ' < A= !B  V' 3  -"c 
 c> 
 ! 4 k(0PTH  .h# 1 
 K  "!High-flux  $ 1  #
 K  "! .h# Low-flux   .!
/Y+B  K  1 Low flux  c>PTH  
Ca c   c>  / a*+P .4 U='A .,Ai 
"9   /  
High-flux  !V0 c 
) !,62.(  
 -"c  |B  c> E!# R< 3

PTH  K  '>  High-flux   .,A
K  Low-flux  s>  
 ! 4  10
@'  -"c 1I B  4   0 .A!#  
-"c q' 
 4 A .4 j9   !A 
-"c q'   ) ! 4 64 -63(. 
-"c    9Bj  Dj 1!I s> 
 n'A,Pearson   ,#Ca  PTH  /
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 High-flux 
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 PPTH  
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K  '>High-flux  B!  10 3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 v!c>  1I ^,# C+  E!#  
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Abstract 
Background: Hemodialysis is the most common alternative therapy in chronic renal failure and 
inadequate dialysis increases the mortality of patients; thus, the dialysis adequacy in these patients is 
important. This study aimed to compare the adequacy if hemodialysis high-flux and low-flux filters in 
Hospital Dialysis Centers of Shahrekord University of Medical Sciences, Iran, and assess its relation 
to other indices for patients with chronic and end-stage renal disease (ESRD).  
Methods: In a randomized clinical trial, 42 patients were performed with low-flux and high-flux 
filters. So, the patients with end-stage chronic kidney disease, with the rate of ultrafiltration of more 
than 3 liters, in the two cross groups underwent hemodialysis with high- and low-flux filters in 2 
months. The indicators for measuring the Kt/V in each dialysis and other lab indices at the beginning 
and the end of each month were measured and compared using SPSS software. 
Findings: At the end of the intervention, significant difference in adequacy of dialysis was observed 
between the two groups of high- and low-flux filtration. Although, both groups of patients had 
adequacy of dialysis in terms of defined standards, but the findings showed that Kt/V in hemodialysis 
significantly was lower in high-flux group (P = 0.013). 
Conclusion: This study showed that the high-flux filters in higher volumes of 3 liters of ultrafiltration, 
increases the average dialysis adequacy more than the low-flux filters. We suggest future studies to 
assess the impact of long-term use of high-flux filters on dialysis efficacy, improved quality of life and 
reduced hospitalization rate in hemodialysis patients and its effect on reducing healthcare costs; 
patients are thereby cost-benefited in using high-flux filters for long term. 
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